Randomized trial of granulocyte-colony stimulating factor (G-CSF) added to CHOP in elderly patients with aggressive non-Hodgkin's lymphoma (NHL).

被引：0
|
作者：
Doorduijn, JK [1 ]
van der Holt, B [1 ]
van der Hem, KG [1 ]
van Imhoff, GW [1 ]
Kramer, MHH [1 ]
van Oers, MHJ [1 ]
Ossenkoppele, GJ [1 ]
Schaafsma, MR [1 ]
Verdonck, LF [1 ]
Verhoef, GEG [1 ]
Steijaert, MMC [1 ]
Lowenberg, B [1 ]
Sonneveld, P [1 ]
机构：
[1] Univ Hosp Dijkzigt, NL-3015 GD Rotterdam, Netherlands
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
575
引用
收藏
页码：133A / 133A
页数：1
相关论文
共 50 条
  • [41] Granulocyte-Colony Stimulating Factor (G-CSF)-Induced Aortitis: A Case Report
    Ito, Masahiro
    Amari, Masakazu
    Sato, Akiko
    Hikichi, Masahiro
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [42] A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma
    Burton, C
    Cunningham, D
    Qian, W
    MacLennan, K
    Hancock, B
    ANNALS OF ONCOLOGY, 2005, 16 : 103 - 103
  • [43] A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma
    C Burton
    D Linch
    P Hoskin
    D Milligan
    M J S Dyer
    B Hancock
    P Mouncey
    P Smith
    W Qian
    K MacLennan
    A Jack
    A Webb
    D Cunningham
    British Journal of Cancer, 2006, 94 : 806 - 813
  • [44] A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma
    Burton, C
    Linch, D
    Hoskin, P
    Milligan, D
    Dyer, MJS
    Hancock, B
    Mouncey, P
    Smith, P
    Qian, W
    MacLennan, K
    Jack, A
    Webb, A
    Cunningham, D
    BRITISH JOURNAL OF CANCER, 2006, 94 (06) : 806 - 813
  • [45] Didanosine (ddI) ameliorates neutropenia and thrombocytopenia in patients with HIV-associated non-Hodgkin's lymphoma (NHL) treated with infusional cyclophosphamide (C), doxorubicin (D), and etoposide (E) plus granulocyte-colony stimulating factor (G-CSF).
    Sparano, JA
    Wiernik, PH
    Hu, X
    Dutcher, JP
    Sarta, C
    Henry, D
    Mason, B
    BLOOD, 1995, 86 (10) : 3724 - 3724
  • [46] Dose-escalation study of CHOP with or without prophylactic G-CSF in aggressive non-Hodgkin's lymphoma
    Itoh, K
    Ohtsu, T
    Wakita, H
    Igarashi, T
    Ishizawa, K
    Onozawa, Y
    Fujii, H
    Minami, H
    Sasaki, Y
    ANNALS OF ONCOLOGY, 2000, 11 (10) : 1241 - 1247
  • [47] Decreased Plasma Levels of Granulocyte-Colony Stimulating Factor (G-CSF) in Patients with Early Alzheimer's Disease
    Laske, Christoph
    Stellos, Konstantinos
    Stransky, Elke
    Leyhe, Thomas
    Gawaz, Meinrad
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (01) : 115 - 123
  • [48] Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
    Bo, Lulong
    Wang, Fei
    Zhu, Jiali
    Li, Jinbao
    Deng, Xiaoming
    CRITICAL CARE, 2011, 15 (01)
  • [49] Fourteen-day CHOP supported with granulocyte colony-stimulating factor in patients with aggressive non-Hodgkin's lymphoma: Results of a phase II study
    Gregory, SA
    Case, DC
    Bosserman, L
    Litwak, DL
    Berry, WR
    Kalman, LA
    Belt, RJ
    Saven, A
    CLINICAL LYMPHOMA, 2003, 4 (02): : 93 - 98
  • [50] Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
    Lulong Bo
    Fei Wang
    Jiali Zhu
    Jinbao Li
    Xiaoming Deng
    Critical Care, 15
12345